Govt to ban semaglutide compounding from October amid patient safety fears
A provider of compounded semaglutide said patient treatment would be disrupted.
The TGA is banning pharmacists from compounding semaglutide and other GLP-1 receptor agonists, starting 1 October.
About 20,000 patients are currently using compounded semaglutide for weight loss, according to Minister for Health and Aged Care Mark Butler.